Therapeuticsmd, Inc.
A maker of women's health medicines, it developed the brands Annovera, a vaginal contraceptive, and BIJUVA and IMVEXXY, hormone therapies for menopause. Founded in 2008 in Boca Raton, Florida, after a medical-device entrepreneur and an obstetrician-gynecologist met in their neighborhood, the name pairs "therapeutics" with the co-founder's medical degree. The firm has since licensed its products to partners and now earns royalties on their sales.
Granted 1.66M · Bought 235.4K · Sold 2.62M
Granted 2.16M · Bought 169.0K · Sold 2.48M
Granted 1.19M · Bought 711.8K
Bought 74.1K · Sold 215.3K
Granted 412.5K · Sold 412.5K
Bought 10.3K
Bought 2.5K
Granted 217.2K · Sold 93.3K
Granted 96.9K · Bought 10.0K
Granted 1.48M · Bought 46.0K · Sold 5.20M
Granted 364.1K · Bought 2.8K · Sold 42.4K
Granted 197.8K · Sold 38.5K
Granted 107.3K · Bought 2.15M · Sold 2.63M
Granted 103.5K · Sold 44.3K
Granted 120.0K · Sold 120.0K
Granted 169.3K · Bought 117.4K
Sold 5.0K
Bought 5.0K
Granted 107.3K · Sold 3.9K
Granted 7.5K
Granted 98.8K · Bought 100.0K
Granted 98.8K · Bought 93.5K
Granted 98.8K · Bought 33.4K
Granted 98.8K · Bought 11.6K · Sold 17.4K
Bought 3.1K
Granted 1.7K · Sold 440
Sold 4.11M
Sold 4.11M
Sold 684.7K
Sold 259.0K
Sold 17.7K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Finizio Robert GCEO, Director · 61 transactions | — | 23.99Mas of May 2021 | 1.66M | 235.4K | 2.62M |
| Milligan John C.K. IVSecretary/CEO of subsidiary · 60 transactions | — | 7.06Mas of May 2021 | 2.16M | 169.0K | 2.48M |
| Rosen David Efraim +1 co-filer10% owner, Director, 10% owner, See Remarks. · 12 transactions | — | 2.95Mas of Nov 2023 | 1.19M | 711.8K | — |
| Segal NicholasDirector · 3 transactions | — | 1.32Mas of Mar 2014 | — | 74.1K | 215.3K |
| Krassan MitchellChief Strategy Officer · 13 transactions | — | 300.0Kas of Feb 2020 | 412.5K | — | 412.5K |
| Jensen Gerald LPresident, Director, 10% owner · 8 transactions | — | 258.9Kas of Aug 2007 | — | 10.3K | — |
| Croff Enterprises IncPresident, Director · 4 transactions | — | 254.5Kas of Jan 2007 | — | 2.5K | — |
| DArecca JamesChief Financial Officer · 2 transactions | — | 123.8Kas of Aug 2021 | 217.2K | — | 93.3K |
| Carroll J MartinDirector · 2 transactions | — | 106.9Kas of Aug 2021 | 96.9K | 10.0K | — |
| Bernick BrianCo-Chief Executive Officer · 52 transactions | — | 76.2Kas of Dec 2022 | 1.48M | 46.0K | 5.20M |
| Walker Marlan DChief Executive Officer · 21 transactions | — | 73.6Kas of Apr 2025 | 364.1K | 2.8K | 42.4K |
| Donegan Michael CPrin. Fin. and Acctg. Officer · 21 transactions | — | 61.9Kas of Apr 2023 | 197.8K | — | 38.5K |
| Collins Cooper C.Director · 14 transactions | — | 60.5Kas of Feb 2025 | 107.3K | 2.15M | 2.63M |
| Borkowski EdwardEVP, Operations · 2 transactions | — | 59.2Kas of May 2021 | 103.5K | — | 44.3K |
| Cartwright Daniel ACFO · 7 transactions | — | 40.0Kas of Dec 2018 | 120.0K | — | 120.0K |
| Thompson Tommy GDirector · 26 transactions | — | 37.5K | 169.3K | 117.4K | — |
| Mandel Richard H JrDirector · 1 transaction | — | 13.1Kas of Jun 2008 | — | — | 5.0K |
| LaPenta Robert V JrDirector · 2 transactions | — | 10.0Kas of May 2014 | — | 5.0K | — |
| Naughton Gail KDirector · 4 transactions | — | 8.5Kas of Feb 2025 | 107.3K | — | 3.9K |
| Ziegler JosephPrincipal Financial Officer · 1 transaction | — | 7.5Kas of Aug 2023 | 7.5K | — | — |
| Bisaro PaulDirector · 4 transactions | — | 5.9Kas of Aug 2022 | 98.8K | 100.0K | — |
| Russell Angus C.Director · 7 transactions | — | 5.8Kas of Aug 2022 | 98.8K | 93.5K | — |
| Ling KarenDirector · 3 transactions | — | 4.6Kas of Aug 2022 | 98.8K | 33.4K | — |
| Musing Jules A.Director · 6 transactions | — | 4.0Kas of Aug 2022 | 98.8K | 11.6K | 17.4K |
| Barlow Jane FDirector · 1 transaction | — | 3.1Kas of Aug 2019 | — | 3.1K | — |
| Glickman Mark ACo-Chief Executive Officer · 2 transactions | — | 1.7Kas of Dec 2022 | 1.7K | — | 440 |
| Sarubbi KimberlyNone · 1 transaction | — | 0as of Dec 2010 | — | — | 4.11M |
| Tjon Robin NatalieNone · 1 transaction | — | 0as of Dec 2010 | — | — | 4.11M |
| Mastropietro Donald RNone · 1 transaction | — | 0as of Dec 2010 | — | — | 684.7K |
| Jensen Development COFormer President, Director, 10% owner · 4 transactions | — | 0as of Jun 2008 | — | — | 259.0K |
| Jensen Julian DDirector · 2 transactions | — | 0as of Jun 2008 | — | — | 17.7K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -19.33M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.